infliximab IV - tocilizumab IV en SC - natalizumab IV - denosumab SC
TED · 628378-2026Contract noticeClosed 15 days ago
Value
Estimated—
Awarded—
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
infliximab IV - tocilizumab IV en SC - natalizumab IV - denosumab SC
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-16 | Spécialités pharmaceutiques à base d'infliximab IV | — BE | 90% |
| 2026-08-04 | 2025/1746 - EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 90% |
| 2026-06-09 | 2025/1746 -EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 90% |
| 2026-10-20 | 2025/1746 - EMICIZUMAB [150 MG/ML 1 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 90% |
| 2026-07-21 | 2023/0491 - TRASTUZUMAB [600 MG/ 5 ML SOL INJ SC FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 90% |
| 2026-09-22 | 2023/0491 - TRASTUZUMAB EMTANSINA [100 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 90% |